| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.19 | 0.0008 |